| (11) | Registration Number: | P20201409 (Validated european patent) | |
| (21) | File number: | P20201409T |
| (22) | Date of filing the request: | 03.09.2020 |
| (45) | Patent Publication Date and Gazette Number: | 27.11.2020 |
| (54) | English Title: | NOVEL PHARMACEUTICAL COMPOSITION |
| (96) | Number of the European patent application: | EP 11849974.8, 20.12.2011 | |
| (97) | Publication data of the European patent application: | EP 2654736, 30.10.2013, 201344, en | |
| (97) | Publication data of the European patent: | EP 2654736, 01.07.2020, 202027, en | |
| (51) | IPC: | A61K 9/28 (2006.01) |
| | | A61K 9/20 (2006.01) |
| | | A61K 31/519 (2006.01) |
| | | A61P 35/00 (2006.01) |
| (73) | Holder(s): | | 1. | Novartis AG, Lichtstrasse 35, 4056 Basel, CH |
| |
| (72) | Inventor(s): | | 1. | Douglas J. DeMarini, 1250 South Collegeville Road, Collegeville, PA 19426, US |
| |
| | | 2. | Ngocdiep T. Le, 1250 South Collegeville Road, Collegeville, PA 19426, US |
| |
| | | 3. | Francisco Henriquez, 1250 South Collegeville Road, Collegeville, PA 19426, US |
| |
| | | 4. | Lihong Wang, 1250 South Collegeville Road, Collegeville, PA 19426, US |
| |
| (74) | Representative: | CPZ - CENTAR ZA PATENTE d.o.o.,
Kutinska 2, 10000 Zagreb, HR
|
| (30) | Priority Data: | | (31) | 201061424967 P | | (32) | 20.12.2010 | | (33) | US |
|
| (86) | PCT Application Number and Date | PCT/US2011066021; 20.12.2011 |
| (87) | PCT Publication Number and Date | WO2012088033; 28.06.2012 |
| (46) | Publication Date of Translation of a European Patent Claims and the Gazette Number: | 27.11.2020 |
| | Annual fee: | 22.11.2024 for the 14th year | |
|
| |